Tenderwize
Wróć do wyszukiwania

Open House Discount Agreements for Axitinib, ATC L01EK01

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 05, 2027 · 250 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Axitinib, ATC L01EK01

60/100

Ocena szansy

PromisingLow complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

60 / 100

Złożoność

20 / 100

Czynniki ryzyka

Agreements automatically lapse if a national or regional discount contract for the same substance is concluded during t...

Paper submission requires two originals and must arrive by 10th if fax/email used; incorrect submission may delay or pr...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Strong opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Open-house model for non-exclusive discount agreements on Axitinib (ATC L01EK01)
  • All pharmaceutical companies meeting eligibility can participate
Pokaż pełne podsumowanie

This is an open-house model, not a competitive procurement. AOK Bayern invites all interested pharmaceutical companies to sign non-exclusive discount agreements for the active substance Axitinib (ATC L01EK01) under §130a Abs. 8 SGB V. All companies meeting eligibility (submitted declaration of reliability) can join. Contracts run from 01.07.2025 to 30.06.2027. No estimated value provided. Submission deadlines: any time until 05.05.2027, but to start at a specific month, documents must be received by the 5th of that month. Documents can be submitted in paper or electronically with qualified electronic signature.

Ryzyka

Agreements automatically lapse if a national or regional discount contract for the same substance is concluded during t...

Paper submission requires two originals and must arrive by 10th if fax/email used; incorrect submission may delay or pr...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical company

Administrative

  • Submit signed contract, annex specifying medicines, and signed declaration of reliability
  • Documents in German or with German translation

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Open House Discount Agreements for Axitinib, ATC L01EK01

Non-exclusive discount agreements for the active substance Axitinib. All eligible pharmaceutical companies can join at any time during the contract period. Contracts are identical and non-negotiable. Early termination possible with one-month notice. Agreements automatically lapse if a national or regional discount contract for the same substance is concluded.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

Jun 2025 - Jun 2027

Kategoria

Pharmaceutical products

Termin

Deadline May 05, 2027

Szczegóły zamówienia

Data publikacji
15 May 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
317253-2025

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30